-
1Academic Journal
Source: Medical Genetics; Том 15, № 5 (2016); 18-23 ; Медицинская генетика; Том 15, № 5 (2016); 18-23 ; 2073-7998
Subject Terms: bisulfite pyrosequencing, CpG-динуклеотиды, эпигенетические биомаркеры, злокачественные новообразования молочной железы, бисульфитное пиросеквенирование, DNA methylation, CpG-sites, epigenetic biomarkers, breast cancer
File Description: application/pdf
Relation: https://www.medgen-journal.ru/jour/article/view/124/112; Warton K, Samimi G. Methylation of cell-free circulating DNA in the diagnosis of cancer. Front Mol Biosci. 2015;2(13): eCollection.; Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.; Vogelstein B, Papadopoulos N, Velculescu VE et al. Cancer genome landscapes. Science. 2013; 339(6127):1546-58.; Кекеева ТВ, Жевлова АИ, Подистов ЮИ. Аномальное метилирование генов-супрессоров опухолевого роста и микросателлитная нестабильность в предраковых состояниях шейки матки. Молекулярная биология. 2006;40:224-230.; van Hoesel AQ, Sato Y, Elashoff DA et al. Assessment of DNA methylation status in early stages of breast cancer development. Br J Cancer. 2013;108(10):2033-2038.; Skvortsova TE, Rykova EY, Tamkovich SN et al. Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer. 2006;94(10):1492-1495.; Ponomaryova AA, Rykova EY, Cherdyntseva NV et al. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients. Lung Cancer. 2013;81(3):397-403.; Botla SK, Gholami AM, Malekpour M et al. Diagnostic values of GHSR DNA methylation pattern in breast cancer. Breast Cancer Res Treat. 2012;135(3):705-713.; Lin SY, Xia W, Wang JC et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000;97:4262-4266.; Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res. 2011;13(3):211.; Moskalev EA, Zavgorodnij MG, Majorova SP et al. Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res. 2011;39(11):e77.; Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11-26.; Klarmann GJ, Decker A, Farrar WL. Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics. 2008;3(2):59-63.; Rush LJ, Raval A, Funchain P et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 2004;64(7):2424-2433.